Skip to main content
. 2021 Mar 26;12:660183. doi: 10.3389/fimmu.2021.660183

Figure 2.

Figure 2

Host directed therapies that block immunopathologic mediated cytolysis. ML, mucosal leishmaniasis; LCL, Localized cutaneous leishmaniasis.